login
drugs clinical trial Hengrui Pharmaceutical Oncology drugs Apatinib
01-05
Angiogenesis cancer cell blood vessels Endothelial inhibitin Anlotinib Apatinib Bevacizumab cancer
12-14
![Hengrui Pharmaceutical: Two tumor drugs were approved for drug clinical trials[fig]](data:image/gif;base64,R0lGODlhAQABAIAAAP///wAAACwAAAAAAQABAAACAkQBADs=)
